As women's smoking rates have caught up with those of men, smoking has emerged as a critical health problem for women. If more specific and effective treatments for women are to be devised, it is important to determine whether previous findings in men can necessarily be generalized to women, or whether biological and/or cultural differences need to be taken into account. Over the past several years, there has been growing recognition that systematic hormonal fluctuations associated with the menstrual cycle have had an impact not only upon reproductive biology but upon numerous other aspects of mood, behavior, and cognitive function. Recent research with women smokers suggests that smoking may be enhanced during menstrual phases associated with physical discomfort and dysphoria and withdrawal symptomatology may be more severe in women who attempt to quit in the latter part of the menstrual cycle.
The specific aims of this renewal project are to carry out a sequence of within-subject, repeated measures studies in women smokers over a f-year period: 1) Stress-induction of smoking behavior and nicotine intake across the menstrual cycle, and their relationship to cyclical changes in behavioral, subjective, and physiological variables, will be explored in Study I; nicotine (self- administered via cigarette smoking) serves as the principal dependent variable. 2) Nicotine's acute effects on physiological, behavioral, and subjective responses and on stress hormones (catecholamines and the pro- opiomelanocortin group) will be examined across the menstrual cycle in Studies II and III; nicotine serves as the independent variable and is administered to the smoker in controlled doses via intranasal aerosol. 3) Differences in ability to stop smoking for a week will be tested in two matched groups asked to abstain at different points in the menstrual cycle in Study IV; this study explores the question of whether phase needs to be taken into account in recommendations for smoking cessation. 4) Differences in nicotine intake in the late luteal phase following mid-cycle opioid blockade using naltrexone will be examined in a double-blind, placebo controlled design in Study V, providing a potential explanation for the apparent increase in reinforcement value for smoking in this phase. Because there has been so little systematic research on the behavioral, subjective, physiological, and neurohumoral manifestations of smoking in women, the initial studies will be largely descriptive, with attempts to elucidate mechanisms underlying the dynamic relations between smoking behavior and the menstrual cycle to be undertaken only after a suitable empirical base is established.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA042730-09S2
Application #
2090899
Study Section
Behavioral Medicine Study Section (BEM)
Project Start
1991-04-01
Project End
1995-03-31
Budget Start
1993-04-01
Budget End
1995-03-31
Support Year
9
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Psychiatry
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Pomerleau, Ovide F; Pomerleau, Cynthia S; Snedecor, Sandy M et al. (2004) Depression, smoking abstinence and HPA function in women smokers. Hum Psychopharmacol 19:467-76
Pomerleau, Ovide F; Fagerstrom, Karl-Olov; Marks, Judith L et al. (2003) Development and validation of a self-rating scale for positive- and negative-reinforcement smoking: The Michigan Nicotine Reinforcement Questionnaire. Nicotine Tob Res 5:711-8
Pomerleau, Ovide F; Pomerleau, Cynthia S; Marks, Judith L et al. (2003) Prolonged nicotine patch use in quitters with past abstinence-induced depressed mood. J Subst Abuse Treat 24:13-8
Pomerleau, Cynthia S; Zucker, Alyssa N; Stewart, Abigail J (2003) Patterns of depressive symptomatology in women smokers, ex-smokers, and never-smokers. Addict Behav 28:575-82
Hudmon, Karen Suchanek; Marks, Judith L; Pomerleau, Cynthia S et al. (2003) A multidimensional model for characterizing tobacco dependence. Nicotine Tob Res 5:655-64
Pomerleau, C S; Brouwer, R J; Pomerleau, O F (2001) Emergence of depression during early abstinence in depressed and non-depressed women smokers. J Addict Dis 20:73-80
Pomerleau, C S; Marks, J L; Pomerleau, O F (2000) Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology. Nicotine Tob Res 2:275-80
Pomerleau, C S; Mehringer, A M; Marks, J L et al. (2000) Effects of menstrual phase and smoking abstinence in smokers with and without a history of major depressive disorder. Addict Behav 25:483-97
Pomerleau, C S; Pomerleau, O F; Namenek, R J et al. (2000) Short-term weight gain in abstaining women smokers. J Subst Abuse Treat 18:339-42
Marks, J L; Pomerleau, C S; Pomerleau, O F (1999) Effects of menstrual phase on reactivity to nicotine. Addict Behav 24:127-34

Showing the most recent 10 out of 39 publications